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Abstract:
Background:
The aim was to study the association between mood and anxiety disorders and the Tako-Tsubo Syndrome (TTS) and to determine the
role of antidepressants and the impairment of quality of life due the comorbid psychiatric disorder.
Methods:
Case-control study: 19 consecutive patients (17 female) with TTS compared to 76 controls without TTS, were randomly selected
from  the  database  of  a  nationwide  epidemiological  study  after  matching  (gender,  age  and  residence)  by  controls.  Psychiatric
diagnoses were carried out according to the ICD-10 using semi-structured interview tools (ANTAS-SCID) administered by clinical
staff. Quality of Life (Qol) was assessed by means of SF-12.
Results:
Only Major Depressive Disorders (MDD) showed higher frequencies in cases with statistical significance difference (p=0.014) as
well as at least one Mood Disorder Diagnosis [MDD or BD] (p=0.002). The lifetime prevalence of at least one anxiety disorder with
no comorbid mood disorder did not show a higher frequency in cases (p=0.57).
The score at SF-12 in the TTS group was similar to those of controls (p=0.71)In the TTS group, the score at SF-12 in people with one
mood or anxiety diagnosis (N=7) was similar to those without mood or anxiety diagnosis (p=0.75). The use of antidepressants was
higher in TTS group (15.79% vs 1.31%; p=0.030).
Conclusion:
The study shows an association between TTS with depressive disorders and antidepressants use and does not confirm the association
with anxiety syndromes. The study suggests the need to investigate the possible interactions between antidepressants use and mood
disorders in studies with appropriate design and sample size.
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1. BACKGROUND
Tako-Tsubo  Syndrome  (or  stress-induced  cardiomyopathy)  is  a  reversible  clinical  entity  that  mimics  acute
myocardial infarction. Peculiar features of this syndrome are the lack of evidence of obstructive coronary artery disease
on emergent coronary angiography and the transient left ventricular wall motion abnormalities most often involving the
apical region that confers to the left ventricle, the typical shape of the pot used for trapping octopus in Japan named as
“Tako-Tsubo Syndrome” [1, 2].
Although extensive myocardial dysfunction often resolves rapidly, mortality is comparable with that of patients
with coronary acute syndromes [3].
The syndrome usually occurs in postmenopausal women and is typically elicited by emotional or physical stress. An
acute increase in cathecolamine surge leading to severe coronary microvascular spasm with myocardial dysfunction has
been proposed as the main pathogenetic mechanism and a prior history of mood and anxiety symptoms was found to be
associated to this syndrome [4]. The latter has been confirmed by the International Tako-tsubo Registry by showing that
lifetime psychiatric affective or anxiety disorders were more frequent in patients with Tako-Tsubo Syndrome than in
patients with acute coronary syndrome (55.8% versus with 25.7% of cases) [3].
However, whether the vulnerable substrate for Tako-Tsubo Syndrome is the history of a mood or anxiety disorder in
itself, due to the chronic distress, or the antidepressant drugs or, as it seems more likely, both psychiatric illness and
treatment, remains unclear. In fact, many antidepressants produce a chronic increase in sympathetic nervous drive in
cardiovascular circulation as a side effect of the increase of catecholamines in the central nervous system, that might be
amplified acutely by a stressful trigger [5].
An  indisputable  fact  is  the  several  cases  of  Tako-Tsubo  Syndrome  reported  in  the  literarture  induced  as  a
consequence of convulsant antidepressant therapy in which the elevated levels of catecholamines subsequent to the
convulsant antidepressant therapy may be implicated [6 - 9].
A first  important step in understanding the meaning of the association between psychiatric disorders and Tako-
Tsubo Syndrome is to see if there is a specific association between particular anxiety or mood disorders. Until now,
studies  have  been  conducted  using  methodologies  that  only  allow broad  diagnoses  of  groups  of  disorders,  such  as
structured clinical brief interviews [10], questionnaires [11], or rating scales [12], which allow the detection of only
anxious or depressive symptoms without a specific diagnosis label.
The aim of this study is to clarify if there is an association between specific mood and anxiety disorders and the
Tako-Tsubo  Syndrome  by  using  a  semi-structured  psychiatric  interview  conducted  by  clinical  staff  that  allows
diagnosis  in  accordance  with  the  ICD-10  system  [13]  and  a  case-control  design.
A secondary aim is to determine the impairment of quality of life due to the Tako-Tsubo Syndrome and the role of
the concomitant psychiatric disorder, as well the role of concomitant life events.
2. METHODS
2.1. Design
It was a case control design.
2.2. Study Sample
The cases  were 19 consecutive patients  with Tako-Tsubo Syndrome admitted to  the Coronary Care Unit  of  the
University Hospital  San Giovanni di  Dio in Cagliari,  Italy between January 2012 and December 2014. The control
group included 76 subjects with no diagnosis of Tako-Tsubo Syndrome randomly selected from the databank of an
epidemiological survey on health and mental health in Italy [14 - 16]. The selection of sex- age- and residence- matched
controls from the 3498 subjects was carried out with a randomized block design. A block that included all eligible age-
matched (± 1 year), sex-matched and residence-matched (by Italian region) controls in the databank was built for each
case. Four individuals per block were drawn for each case, excluding the selected subjects from the remaining blocks.
2.3. Psychiatric Diagnosis Interview, Tools, and Psychiatric Assessment
Patients were assessed one month after the acute events. The psychiatric interviews were conducted by means of the
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“Advanced Neuropsychiatric Tools and Assessment Schedule” (ANTAS) [17].  A semi-structured clinical interview
derived in part from the SCID-I non-patient version (SCID-I/NP) [18] was used to assess the presence of psychiatric
disorders according to the ICD-10 diagnosis [13].
The ANTAS tool was administered by clinical staff (physicians, psychologists) with adequate training. A previous
study [17] pointed out that diagnoses resulting from the ANTAS interview were comparable and reable to those found
with SCID.
A questionnaire on psychotropic drug consumption, prescription circumstances and health services utilization was
also adminstered in cases and controls [17].
The perceived quality of life was measured by means of the Short Form Health Survey (SF-12) [19] in the Italian
version [20]. The SF-12 components are the seven dimensions: activity, limitations due to health conditions, emotional
state,  physical  pain,  perception  of  general  health,  vitality,  social  relationship  and  psychosocial  disability.  The  tool
measures the month prior to evaluation and higher scores correspond to a better quality of life.
2.4. Diagnosis of Tako-Tsubo Syndrome
The Mayo Clinic criteria were followed in diagnosing Tako-Tsubo Syndrome [21, 22], including:
Transient regional left ventricular systolic dysfunction;1.
Absence of obstructive coronary disease or acute plaque rupture (on angiography);2.
New mild or moderate ECG abnormalities (such as ST elevation or T inversion) or elevation in cardiac troponin;3.
Exclusion of pheochromocytoma or myocarditis.4.
2.5. Screening Controls for Tako-Tsubo Syndrome
During the interviews of the controls, each was asked about general wellbeing, consultation with physicians and
diagnosis of illness, and medical tests they underwent routinely (e.g., work/education periodical controls or driver’s
license or hunter’s license eligibility tests). Diagnosis of physical illness was reported on a structured form. People with
acute or chronic myocardiopathy were excluded.
3. DATA ANALYSIS
Lifetime prevalence of ICD-10 [13], Major Depressive Disorder (MDD), Bipolar Disorder (BD) (including Bipolar
I  and  Bipolar  II),  Post-Traumatic  Stress  Disorder  (PTSD),  Panic  Disorder  (PD)  and  Generalized  Anxiety  Disorder
(GAD)  were  calculated  in  cases  and  controls.  The  odds  ratio  for  each  ICD-10  diagnosis,  as  well  as  for  all  mood
disorders,  for  all  anxiety disorders without  comorbidity with mood disorders and for  all  mood or anxiety disorders
(dependent  variables)  were  calculated  using  the  control  group  as  a  “pivot”  with  univariate  analysis  (owing  to  the
matching method, the groups were balanced by age and gender). The analysis of variance (ANOVA one-way) was used
for  measuring  the  parametric  variables;  the  χ2  test  was  used  for  nonparametric  variables.  The  odds  ratio  and  95%
confidence intervals (OR 95% CI) were calculated with Miettinen’s simplified method.
4. RESULTS
The study samples were represented by 19 cases (17 female) with a diagnosis of Tako-Tsubo Syndrome and by a
control group of 76 subjects (68 females) without a diagnosis of Tako-Tsubo Syndrome; the matching method allowed
controls  to  be  perfectly  homogeneous  with  cases  by  age  and  gender.  The  characteristics  of  cases  and  controls  are
reported in Table 1.
Table 1. Demographic characteristics of cases and controls.
Characteristics Cases Controls
Sample size 19 76
Gender (Female) 17 68
Age (mean ± sd) 63.26 ± 9.21 63.26 ± 9.03
Table 2 shows the lifetime prevalence and the measure of association of psychiatric disorders (MDD, BD, PTSD,
PD and GAD) as well as all people with at least one mood disorder and all people with at least one anxiety disorder
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without comorbidity with mood disorders; all people with at least one mood or anxiety disorder in cases and controls.
All psychiatric disorders evaluated in this study showed a higher prevalence in cases, but only in MDD, the difference
reached statistical significance (26.3%)% vs 6.57%; χ2= 6.27, p=0.014) as well as the association of people with at least
one mood disorder diagnosis and Tako-Tsubo Syndrome (31.5% vs 6.57%; χ2= 9.27, p=0.002). On the contrary, the
lifetime prevalence of  people with at  least  one anxiety disorder  without  mood disorder  showed a low frequency in
patients with Tako-Tsubo Syndrome. The difference versus controls did not reach statistical significance (10.52% vs
3.95%; χ2 with Yates correction 0.33, p=0.57).
Table 2. Lifetime prevalence of ICD-10 psychiatric disorders in cases and controls.
Psychiatric Disorders
Cases Controls
χ2 p OR CI 95%
(N=19) (N=76)
Major Depressive
Disorder
5 (26.3%) 5 (6.57%) 6.27 0.014 4.92 1.05 – 23.52
Bipolar
Disorder
1 (5.26%) 0 (0%) 0.57 * P=0.45 Not Calc -----
Post-Traumatic Stress Disorder 1 (5.26%) 2 (2.63%) 0.02* 0.98 2.13 0.08-35.95
Generalized Anxiety Disorder 2 (10.53%) 2 (2.63%) 0.80* 0.37 4.35 0.40-47.74
Panic Disorder 1 (5.26%%) 3(3.94%) 0.01* 0.99 1.35 0.05- 16.19
Any Mood
Disorder
6 (31.5%) 5 (6.58%) 9.28 0.002 6.55 1.47-30.09
Any Anxiety Disorder
(without Mood Disorder)
1 (5.26%) 3 (3.94%) 0.01* 0.99 1.35 0.05-16.19
Any Mood or Anxiety
Disorder
7 (36.84%) 8(10.52%) 9.64 0.002 5.95 1.52-23.19
Use of Antidepressants in the last month 3(15.79%) 1 (1.31%) 4.71* 0.030 14.06 1.17-376.14
Use of Antidepressants in the last month, standardized by
Depressed in controls
1,77(9.31%) 1 (1.31%) 3.43* 0.067 7.70 0.45-238.21
*Yates correction
The  SF-12  mean  score±sd  in  the  Tako-tsubo  group  was  34.76±6.92,  versus  35.35±6.23  in  the  control  group
(ANOVA 1 way: df 1,93,94; F=0.4; p=0.71); the SF-12 mean score±sd in people with one mood or anxiety diagnosis in
the Tako-tsubo group (N=7) was 34.00±2.92, versus 35.17±9.25 in people of the Tako-tsubo group without anxiety or
mood diagnosis (ANOVA 1 way: df 1,17,10; F=0.104; p=0.75). In 17 out of 19 (84.47%) patients with Tako-Tsubo
Syndrome, at least one relevant life event (such as death or severe illness of a relative, job loss, serious bickering in
family or with friends) was found one month prior to hospitalization. The two cases without relevant life events showed
no  association  with  psychiatric  disorders,  and  the  frequency  of  prior  life  events  in  people  with  Tako-tsubo  and
psychiatric  disorders  compared  to  those  with  Tako-tsubo  but  without  them  (Fisher  exact  test  =  0.508)  showed  no
statistical significance.
The use of antidepressants in the month prior the interview, was found in 3 (15.79%) out of patients with Tako-
Tsubo  Syndrome  and  in  1  (1.31%)  out  of  subjects  in  the  control  group  (χ2  with  Yates  correcrion  =4.71;  p=0.030;
OR=14.06; CI95% 1.17-376.14). Out of 3 cases using antidepressants in Tako-tsubo group, 1 was diagnosed of MDD, 1
of BD and 1 had no diagnosis of mood disorders at ANTAS-SCID; the control using antidepressants diagnosed MD.
After direct standardization considering the freqeuency of mood disorder in the control group, the association with the
use  of  antidepressants  and  Tako-Tsubo  Syndrome  became  weak,  and  it  was  found  at  the  limit  of  the  statistical
significance (9.3% vs 1.3%; χ2=0.064).
5. DISCUSSION
Our work has confirmed the association of the Tako-Tsubo Syndrome with mood disorders, and with depressive
disorders in particular. Our data do not appear to confirm the association between Tako-tsubo and anxious syndromes
previously reported in literature [10, 12, 23].
The study highlighted an association between Tako-Tsubo Syndrome and the use of antidepressants, but the sample
is too small to perform a multivariate analysis to study the interaction of the two factors. The standardization of the case
sample based on the frequency of mood disorders in the controls reduces the strength of the association between Tako-
Tsubo Syndrome and the use of antidepressant drugs (in this way irrespective of the presence of mood disorders) at the
limits of the statistical significance.
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The divergence in the association with Tako-tsubo e Anxiety Disorders shown in literature data may be because this
is the first study to have used diagnoses according to international criteria based on semi-structured clinical interviews
conducted by the clinical staff [17, 23]. In our survey, we separately analyzed the patients with anxiety disorders from
those with comorbid anxiety-depression in order to understand if anxiety alone may be a determinant or if comorbidity
with mood disorder could be a confounding factor.
Some previous studies used an anxiety disorder diagnosis in accordance with international classification systems
[24] such as DSM-IV TR [18]. However, the diagnosis was based on clinical records and therefore, not verified through
semi-structured  interviews,  which  is  recognized  as  the  method  most  capable  to  producing  reliable  diagnoses  in
psychiatry. Other surveys adopted screening by brief structured clinical interviews [10], questionnaires [11], or rating
scales [12] but this is the first study to the best of our knowledge that used a more complex methodology.
Anxiety and depression are often associated, especially in cardio-circulatory disorders [25 - 28]. However, in the
broad  spectrum  of  mood  and  anxiety  disorders,  there  are  different  disorders  requiring  even  different  treatments.
Although many antidepressants are also indicated in anxiety disorders, they are rarely used in anxiety disorders not
associated with depression in Italy [29].
If one attempts to gain a better understanding of whether the association of Tako-Tsubo Syndrome with depressive
disorders is at least partly due to the use of antidepressants, adequate diagnoses should be used and the anxiety and
depression disorders should be clearly distinguished.
On the other hand, the results may be affected by the fact that a study with a small sample size does not have the
power to show differences in the association of Tako-tsubo with anxiety disorders that would have emerged in a larger
sample. In any case, it must be emphasized that anxiety disorders have high rates of prevalence in the community: for
example, a 12-month prevalence of 1.9-5.1% only for Generalized Anxiety Disorders (GAD) [30]. With similar or even
lower frequencies in the community, depressive disorders were found to be associated with Tako-Tsubo Syndrome in
our sample. It has often been found that Tako-Tsubo Syndrome can be a consequence of stress and that the underlying
element of the association may be due to the high stress associated with depressive anxiety disorders [10].
The data of our study neither reinforce nor contradict  this  hypothesis,  but  are based on theories that  depressive
lifetime disorders may lower the vulnerability to stress and to the stress linked to life events [31]. In our sample, we
found high percentages of both depressive disorders and life events in people with Tako-Tsubo Syndrome; these are the
elements that may suggest a role of depressive disorders per se, independently of the treatment as a possible causal
factor. On the other hand, the cases in our observations showed no impairment of the quality of life of those with Tako-
Tsubo Syndrome only or, above all, of those with associated mood disorder, so that one may suspect that the effect on
stress of the mood disorders alone may not be sufficient to support that the cause of the association is the depressive
disorders alone.
6. LIMITS
A limitation  of  this  survey  is  the  fact  that,  while  the  cases  received  a  diagnosis  of  Tako-Tsubo  Syndrome in  a
clinical  setting according to  the standard criteria,  in  the control  sample,  the diagnoses were based only on medical
history and previous investigations. Thus, a number of people who screened negative for Tako-Tsubo Syndrome may be
undiagnosed. But this limit does not detract from the relevance of the association with mood disorders, because, in the
light of possible false positives in the control group, it will only decrease the measure of association between cases and
controls. Also given the low frequency of the Tako-Tsubo Syndrome, the chance of a case between the controls is really
low.
CONCLUSION
Our work, first carried out with psychiatric semi-structured interviews administered by clinicians, has confirmed the
association of the Tako-Tsubo Syndrome with mood disorders and with depressive disorders in particular.
The results do not appear to confirm the association between Tako-Tsubo Syndrome and anxious syndromes.
Data on the use of antidepressants suggests an effect of these drugs regardless of the effect of depression but the
results are not conclusive. The study suggests the need for studies with adeguate sample size and methods to better
define if there is an independent role of the two factors (depressive disorders and antidepressants use) and/or a possible
interaction.
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